Named as a key player in 99 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Atopic Dermatitis Drugs | Pharmaceuticals | $11.2 Bn | 12.2% |
| Anti-Nerve Growth Factor | Pharmaceuticals | – | – |
| Atherosclerosis Drugs | Pharmaceuticals | – | – |
Named as key players in the same markets as Regeneron Pharmaceuticals, Inc. (number of shared markets).
Pfizer Inc.3 shared markets
Sanofi3 shared markets
Bristol-Myers Squibb Company2 shared markets
Teva Pharmaceutical Industries Ltd.2 shared markets
AbbVie Inc.1 shared market
Amgen Inc.1 shared market
Astellas Pharma Inc.1 shared market
AstraZeneca1 shared market
Search all reports for Regeneron Pharmaceuticals, Inc. All companies